ENTX ▼ -2.6% - Entera Bio Ltd. $ENTX - Entera Presents Markedly Enhanced Anabolic Effects of EB613 (First-in-Class Oral PTH(1-34) Tablet) in Postmenopausal Women with Osteoporosis at High Risk of Fracture and Showcases Phase 3 Design at ASBMR 2026 Annual Meeting 13-OCT-2026 07:00 AM ET